Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

38results about How to "Guaranteed specificity" patented technology

Conserved neutralizing epitope QT7 of the major glycoprotein GP5 of the North American porcine reproductive and respiratory syndrome virus envelope, nucleic acid molecules, expression vectors, neutralizing antibodies and their applications

ActiveCN118496323Bguaranteed specificityGuaranteed sensitivitySsRNA viruses positive-senseVirus peptidesAgglutinating antibodyTGE VACCINE
The present invention discloses a conserved neutralizing epitope QT7 of the main glycoprotein GP5 of the envelope of North American porcine reproductive and respiratory syndrome virus (PRRSV-2), a nucleic acid molecule, an expression vector, a neutralizing antibody and its application. The present invention inserts the neutralizing epitope QT7 into the Peg pili of Salmonella pullorum, introduces the inert carrier bacteria S9H to obtain a recombinant bacterium, and the surface of the recombinant bacterium can functionally express and display the neutralizing epitope QT7, mixes with the pig-derived immune serum on a glass plate, and determines the positive and negative nature of the reaction by observing whether agglutinated particles visible to the naked eye are produced within 2 minutes. The agglutination test can qualitatively and quantitatively determine the agglutination antibody, and the agglutination antibody level measured by the agglutination test directly mediated by the neutralizing epitope antigen QT7-antibody is strongly positively correlated with the PRRSV-2 neutralizing antibody level tested by the classical cell neutralization test, so that the present invention can be used to detect whether there is anti-PRRSV-2 neutralizing antibody and the neutralizing antibody level in the serum sample, and has potential application prospects in the immune effect of PRRSV-2 vaccine, the evaluation and prevention and control of anti-PRRSV-2 neutralizing antibodies.
Owner:YANGZHOU UNIV

BMS upper computer system

The invention provides a BMS upper computer system, and relates to the technical field of upper computer control, the BMS upper computer system comprises a BMS upper computer and a BMS, the BMS upper computer determines key data of the BMS according to a connection instruction, and sends a request seed message to the BMS; the BMS receives the request seed message; based on the request seed message, determining seed data according to the random factor, and sending the seed data; the BMS upper computer receives seed data returned by the BMS; based on a preset encryption algorithm, determining a first encryption seed result according to the key data and the seed data; the BMS determines a second encryption seed result based on a preset encryption algorithm according to the key data and the seed data, and verifies the first encryption seed result and the second encryption seed result; and when the first encryption seed result and the second encryption seed result are the same, connecting a BMS upper computer, and sending an identification binding success message to the BMS. According to the invention, the safety can be improved.
Owner:HANGZHOU JIUYI INTELLIGENT TECH CO LTD

Preparation method and application of ultra-sensitive electrochemical immunosensor for detecting MX1 protein based on nano composite material

The invention relates to the technical field of electrochemical immunosensors, in particular to a preparation method and application of an ultra-sensitive electrochemical immunosensor for detecting MX1 protein based on a nano composite material, and the preparation method comprises the following steps: S1, pretreating a glassy carbon electrode; s2, modifying with thiolated graphene oxide; s3, gold nanoparticle modification; s4, carrying out antibody immobilization; and S5, carrying out bovine serum albumin sealing treatment. The kit has ultrahigh sensitivity and high specificity, the detection method is simple, convenient and rapid, multiple signal amplification mechanisms and wide clinical application prospects are achieved, and early diagnosis and clinical monitoring of virus infection are facilitated.
Owner:NANJING TECH UNIV

Multi-adapter fine-tuning automobile question and answer method, computer equipment and storage medium

The invention provides a multi-adapter fine-tuning automobile question and answer method, computer equipment and a storage medium. The method comprises the following steps: establishing and pre-training a base large model; performing fine tuning on the base large model based on the maintenance fault problem data set to obtain a maintenance fault adapter; performing fine adjustment on the base large model based on the vehicle use problem data set to obtain a vehicle use problem adapter; performing fine tuning on the base large model based on the general field problem data set to obtain a general field problem adapter; and performing fine adjustment on the base large model based on the intention recognition task data set to obtain an intention recognition adapter. According to the invention, fine adjustment can be carried out according to problems in different fields, and the specificity of each field is ensured, so that the precision of field adaptation is improved, and consistent performance is ensured. The method is an important improvement on an existing single fine adjustment method, and the problem of field deviation can be effectively solved.
Owner:BEIJING BAICHEBAO TECH CO LTD

Head and neck squamous cell carcinoma organoid and culture method, culture medium and application thereof

The invention discloses a head and neck squamous cell carcinoma organ as well as a culture method, a culture medium and application thereof. The culture medium is prepared from the following components based on Advanced DMEM / F12: 1 percent of Antibiotic-Antibiotic, 1 percent of GlutaMAX, 1 percent of HEPES buffer solution, 50ng / ml of FGF-10, 50ng / ml of EGF, 1nM of bFGF, 500ng / ml of Wnt3a recombinant protein, 500ng / ml of Noggin recombinant protein, 0.1 mu g / ml of R-spondin-1 recombinant protein, 1mM of N-acetylcysteine, 10mM / ml of nicotinamide and 1x of B27 supplement. The culture medium and the culture method disclosed by the invention are particularly suitable for culturing head and neck squamous cell carcinoma organoid, and the obtained organoid has important significance for researching tumor generation, a unique invasive growth mechanism, prognosis, therapeutic targets, drug screening and the like, and has wide application prospects.
Owner:SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

A Cadmium Ion Optical Fiber Sensor Based on Asymmetric Structure

The invention discloses a cadmium ion optical fiber sensor based on an asymmetric structure, comprising a broadband light source, a constant temperature and humidity chamber, a cadmium ion solution, a spectrometer, a sensing structure and a fiber Bragg grating; the fiber Bragg grating and the sensing structure are both placed in a cadmium ion solution, and the cadmium ion solution is always placed in a constant temperature and humidity chamber; Bragg reflection occurs when the light emitted by the broadband light source passes through the fiber Bragg grating, and the transmitted light reaches the light splitting dislocation area through the input end optical fiber and is divided into two parts of light, one part of the light propagates in the core of the optical fiber in the sensing area, and the other part of the light is transmitted in the sensing film and cladding of the optical fiber in the sensing area, and is combined together through the coreless optical fiber in the light combining area to generate interference phenomenon, and finally transmitted to the spectrometer through the output end optical fiber jumper. The relatively excellent sensing structure is combined with a hydrogel that can specifically bind to an insulator, and the detection limit is low, and it has the advantages of low cost, high sensitivity, high accuracy, environmental protection and high efficiency.
Owner:SOUTH CHINA NORMAL UNIV

P53 gene detection kit based on non-specific index-free RCA activated CRISPR / Cas12a and application of p53 gene detection kit

The invention discloses a p53 gene detection kit based on CRISPR (clustered regularly interspaced short palindromic repeats) / Cas12a (CRISPR / Cas12a) activated by RCA (non-specific index free) and application of the p53 gene detection kit. The kit comprises a nicking enzyme triggered target nucleic acid circulating system, a nicking enzyme induced index RCA amplification system and a CRISPR / Cas12a reaction system, the detection method is simple and easy to operate, isothermal amplification is adopted, precise temperature control equipment is not needed, cost is low, universality is good, accuracy is high, detection sensitivity is high, the lowest detection limit is as low as 0.77 fM, and the detection method can be used for p53 gene detection.
Owner:THE SECOND AFFILIATED HOSPITAL ARMY MEDICAL UNIV

Basic data intelligent management method and system

The invention relates to the technical field of data management, in particular to a basic data intelligent management method and system, and the method comprises the following steps: a superior leader creates a corresponding ledger according to a data collection requirement, and appoints the basic attributes of the ledger, including a department to which the ledger belongs, an update period and a division to which the ledger belongs; the ledger creator distributes ledger permissions to data leaders and basic level individuals of all departments through permission management and distribution; a base-level user receives a standing book filling prompt and can select single filling or batch data import; the base data intelligent management method and system provided by the invention have the beneficial effects that a superior leader can flexibly create a corresponding ledger according to a specific ledger task requirement. According to the method, the data leader is endowed with the authority after being created, the authority can be accurately allocated to basic-level individual users by the data leader through an authority allocation mechanism, and the process ensures the security of the data and the specificity of operation and also ensures the orderliness of information flow.
Owner:SHANDONG LANGCHAO YUNTOU INFORMATION TECH CO LTD

A human papillomavirus typing primer set for high-throughput sequencing of targeted pathogens and its screening method

The present invention discloses a human papillomavirus typing primer set for targeted pathogen high-throughput sequencing and a screening method thereof. The primer set of the present invention has the advantages of high specificity, good stability, absence of primer dimers and hairpin structures, low cost, etc., and can be applied to targeted amplification, library construction, targeted pathogen high-throughput sequencing and subsequent bioinformatics analysis of pathogen-infected samples, and can efficiently and accurately detect and classify multiple HPV types.
Owner:广州凯普医学检验所有限公司 +2

Acid-resistant protective film liquid for ultra-thin glass edge processing as well as preparation method and application of acid-resistant protective film liquid

The invention belongs to the technical field of glass processing, and relates to an acid-resistant protective film liquid for ultrathin glass edge processing, and a preparation method and application thereof. The acid-resistant protective film liquid comprises the following components in parts by mass: 100 parts of phenolic resin with different molecular weights; 25 to 35 parts of acrylic resin; 5.1-10 parts of an additive; the additive comprises a flatting agent and a tackifier; and 520-560 parts of a solvent. The preparation method comprises the following steps: mixing phenolic resins with different molecular weights, mixing with a solvent, and heating and stirring until the phenolic resins are completely dissolved to obtain a phenolic resin solution; mixing acrylic resin with a solvent, heating and stirring until the acrylic resin is completely dissolved to obtain an acrylic resin solution; mixing the phenolic resin solution and the acrylic resin solution to obtain a mixed resin solution; and mixing the additive with the mixed resin solution, and uniformly stirring to obtain the acid-resistant protective film solution. The problems of film thickness uniformity and poor base material adhesion of the acid-resistant protective film liquid are effectively solved, and the stability of the acid-resistant protective film liquid is improved.
Owner:SHAANXI IRICO NEW MATERIAL CO LTD +1

Method for detecting circrna based on argonaute protein and rolling circle amplification

The application discloses a circRNA detection method based on Argonaute protein and rolling circle amplification. The method comprises the following steps: mixing a sample containing target circRNA to be detected with a specific reverse transcription primer and reverse transcriptase to obtain long-chain cDNA; mixing the obtained long-chain cDNA with pfAgo, gDNA and a DNA nucleic acid probe to carry out a reaction, and calculating the content of the target circRNA according to the fluorescence signal of the reaction mixture; the nucleotide sequence of the gDNA is specifically complementary to the cDNA sequence obtained by reverse transcription of the circRNA; the sequence of the DNA nucleic acid probe is specifically complementary to the sequence of the cDNA after one cutting of the cDNA by the pfAgo; and the DNA nucleic acid probe is a single-stranded DNA probe with a fluorescent label. The application can realize high-sensitivity, high-specificity and multiple target simultaneous analysis and detection of potential diagnostic biomarkers of liver cancer such as hsa_circ_0001445 and hsa_circ_0001141.
Owner:ZHEJIANG UNIV

Pneumonic genome detection system and method based on throat swab sample

The invention relates to the technical field of molecular biology, in particular to a pneumonia genome detection system and method based on a throat swab sample. The method comprises the following steps: obtaining a pharynx throat swab sample solution, and adding lysozyme for sample digestion to obtain a sterile throat swab sample; the method comprises the following steps: putting a sterile throat swab sample into a nucleic acid extraction kit, and carrying out nucleic acid quality screening treatment on the sterile throat swab sample to obtain a sterile throat swab nucleic acid high-quality sample; the method comprises the following steps: obtaining a pneumonia related pathogen historical genome sequence, and carrying out related pathogen primer design and PCR amplification library construction to obtain a throat swab nucleic acid PCR amplification sequence library; and performing high-throughput sequencing treatment and genomic sequence pathogen comparison detection on each group of throat swab nucleic acid pneumonia gene sequences in the throat swab nucleic acid PCR amplification sequence library to obtain a throat swab sample pneumonia pathogen genome detection result. According to the invention, accurate identification and quantitative analysis of pneumonia pathogens can be realized.
Owner:GUANGZHOU LANWEI MEDICAL LAB CO LTD

Nucleic acid detection kit for typhoid fever, paratyphoid fever, cholera, shiga and dysentery and application

The invention discloses a nucleic acid detection kit for typhoid fever, paratyphoid fever, cholera, shigella and dysentery. The nucleic acid detection kit comprises a multiple fluorescent PCR detection system, and the multiple fluorescent PCR detection system comprises a typhoid fever salmonella primer probe, a paratyphoid fever salmonella primer probe, a vibrio cholera primer probe, a dysentery amoeba primer probe and a shigella primer probe; according to the kit, specific and conservative characteristic genes of different bacteria species are selected for primer probe design, so that the specificity, the accuracy and the sensitivity of detection are ensured.
Owner:JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION (PUBLIC HEALTH RESEARCH INSTITUTE OF JIANGSU PROVINCE)

Electrochemical biosensor for detecting acetylcholin esterase as well as preparation method and application of electrochemical biosensor

The invention relates to an electrochemical biosensor for detecting acetylcholin esterase based on a gold nanoparticle-aptamer / graphite paper array electrode as well as a preparation method and application of the electrochemical biosensor. The electrochemical biosensor is a graphite paper array electrode formed by encircling a plurality of pieces of graphite paper into a ring, gold nanoparticles are modified on the surface of the graphite paper array electrode, and a three-electrode system consisting of a working electrode, a counter electrode and a reference electrode of a nucleic acid aptamer for specifically recognizing acetylcholin esterase is connected to the gold nanoparticles. When the electrochemical biosensor is used for detecting acetylcholin esterase, the electrochemical biosensor has more excellent sensitivity and conductivity, and is low in price, simple, convenient and feasible.
Owner:GUANGDONG PHARMA UNIV

Nucleic acid sequence combination for mycoplasma detection, kit and use method of kit

The invention belongs to the technical field of molecular biology, and particularly relates to a nucleic acid sequence combination for mycoplasma detection, a kit and a use method of the kit. The detection kit comprises a PCR (Polymerase Chain Reaction) specific primer probe, a buffer solution, Taq enzyme and an internal quality control (IC), wherein the primer probe comprises forward and reverse amplification primers aiming at mycoplasma and an internal standard and a detection probe; the sequences of the primers are shown as SEQ ID NO.1-SEQ ID NO.7 respectively. The kit disclosed by the invention can be used for detecting mycoplasmas and accurately identifying whether various biological samples such as cell banks, production raw materials, virus seeds, cell cultures and the like are polluted by the mycoplasmas, and has high sensitivity, specificity and detection accuracy. Meanwhile, by adding internal quality control (IC), whether the to-be-detected sample inhibits the amplification reaction or not can be judged, and a false negative result is prevented from being generated.
Owner:JIANGSU UNINOVO BIOLOGICAL TECH

A cross-linked spore phenol adsorbent based on nucleic acid aptamer functionalized magnetic hydrophobic polymer and its application

ActiveCN116440874BEnhanced hydrophobic interactionsguaranteed specificityIon-exchange process apparatusOther chemical processesAptamerPolymer science
The present invention provides a cross-linked spore phenol adsorbent based on a nucleic acid aptamer functionalized magnetic hydrophobic polymer and its application, which is obtained by coupling a nucleic acid aptamer with a magnetic hydrophobic polymer, wherein the magnetic hydrophobic polymer is a copolymer of magnetic nanoparticles, methyl methacrylate and vinyl ethylene carbonate, wherein the nucleic acid aptamer can specifically identify AOH, and the magnetic hydrophobic polymer is designed according to the molecular structure of AOH, and can increase the hydrophobic interaction with AOH, and under the synergistic effect of the nucleic acid aptamer and the magnetic hydrophobic polymer, the efficient and highly specific adsorption of AOH is achieved. The cross-linked spore phenol adsorbent based on a nucleic acid aptamer functionalized magnetic hydrophobic polymer provided by the present invention can be used for the efficient and highly specific adsorption of toxin target molecules having a hydrophobic class under the premise of changing the corresponding aptamer to which it is bonded.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES

Pet breast cancer lesion identification method based on abnormal sample DBT image

This invention discloses a method for identifying pet breast cancer lesions based on abnormal sample DBT images in the field of pet medical imaging technology. The method acquires and preprocesses 3D images of abnormal DBT in pet breast tissue with lesion annotations, generating a 2D section sequence and a three-branch sample set. A pet breast lesion feature encoder is obtained through lesion prior comparison self-supervised training. Human breast DBT anatomical knowledge is aligned with pet data to achieve cross-species knowledge transfer. The 2D section sequence is input into the encoder and detection head to obtain 2D lesion detection results. A 3D lesion body is generated through lesion spatial trajectory growth and aggregation, and the final lesion identification result is output. This invention achieves high-precision detection relying solely on abnormal samples, eliminating the need for normal samples, diffusion models, and knowledge distillation. It adapts to the physiological structural characteristics of pet breast tissue, improves the detection effect of small lesions and the accuracy of 3D localization, and is suitable for rapid clinical screening of pet breast cancer.
Owner:YANGZHOU UNIV

Septin 9 methylation detection composition and use thereof

ActiveCN114717309BHigh Specific Multiplex DetectionHigh Sensitive Multiplex DetectionGeneticsBiochemistry
The application provides a Septin9 methylation detection composition and application thereof, and the composition comprises a methylation-dependent restriction enzyme, a capture oligonucleotide, a universal primer and a Septin9 methylation-specific primer; the capture oligonucleotide comprises a first universal sequence, a folding sequence and a binding capture sequence from 5' end to 3' end in sequence; the folding sequence is at least partially identical to a 5' end sequence of a Septin9 methylation site after the methylation-dependent restriction enzyme is cut; and the binding capture sequence is specifically bound to a fragment region where the detected Septin9 methylation site is located. The application is based on a methylation-dependent restriction enzyme and a universal primer fluorescence quantitative PCR technology, does not need bisulfite conversion, and realizes accurate and specific Septin9 methylation detection.
Owner:SHANGHAI HEALZONE BIOTECHNOLOGY CO LTD

Monoclonal antibody specifically combined with clostridium perfringens beta2 toxin recombinant protein, hybridoma cell strain and application

The invention belongs to the technical field of biology, and discloses a monoclonal antibody specifically combined with clostridium perfringens (C.p) beta 2 toxin recombinant protein, a hybridoma cell strain and application. The invention provides a monoclonal antibody which is specifically combined with beta 2 toxin protein and a hybridoma cell strain CPB2-2A4 which secretes the monoclonal antibody and has the preservation number of CCTCC NO: C2024312, the monoclonal antibody only reacts with the C.p beta 2 toxin protein and does not have cross reaction with other pathogens which infect cattle and sheep, and the specificity is extremely high; according to the kit, a competitive ELISA technology is utilized, a mouse monoclonal antibody specifically combined with C.p beta2 toxin recombinant protein is taken as a competitive antibody, C.p beta2 toxin antibodies in serum of various animal sources can be detected, and species limitation of sample sources is avoided. In addition, the kit is good in repeatability. The kit has low technical requirements during operation, can be widely popularized and used in production, and is applied to C.p epidemiological investigation and vaccine immune level monitoring.
Owner:LANZHOU VETERINARY RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES(LANZHOU BRANCH CENTER OF CHINA ANIMAL HEALTH & EPIDEMIOLOGY CENTER)

CircRNA detection method based on Argonaute protein and rolling circle amplification

The invention discloses a circRNA (Ribonucleic Acid) detection method based on an Argonaute protein and rolling circle amplification. The method comprises the following steps: mixing a to-be-detected sample containing target circRNA with a specific reverse transcription primer and reverse transcriptase, and reacting to obtain long-chain cDNA (complementary deoxyribonucleic acid); mixing the obtained long-chain cDNA with pfAgo, gDNA and a DNA nucleic acid probe for reaction, and calculating the content of the target circRNA according to a fluorescence signal of a reaction mixed solution; the nucleotide sequence of the gDNA is specifically complementary to the cDNA sequence obtained by circRNA reverse transcription, the sequence of the DNA nucleic acid probe is specifically complementary to the sequence of the cDNA subjected to primary cutting by pfAgo, and the DNA nucleic acid probe is a single-stranded DNA probe with a fluorescent label. According to the invention, high-sensitivity, high-specificity and multi-target simultaneous analysis and detection of potential liver cancer diagnosis biomarkers such as hsacirc0001445, hsacirc0001141 and the like can be realized.
Owner:ZHEJIANG UNIV

Kit for determining p2PSA based on latex enhanced immunoturbidimetry, preparation method and detection method

The invention relates to the technical field of immunodetection, in particular to a kit for determining p2PSA based on latex enhanced immunoturbidimetry, a preparation method and a detection method. The kit comprises a reaction solution and a latex antibody reagent, the reaction liquid comprises at least one of a buffer solution, inorganic salt, a sensitizer, a surfactant, a blocking agent and a preservative; the latex antibody reagent comprises a mixture of a first latex antibody reagent and a second latex antibody reagent; the first latex antibody reagent is formed by coupling a polyclonal antibody of p2PSA and large-particle-size latex microspheres; the particle size range of the large-particle-size latex microspheres is 172-405 nm; the second latex antibody reagent is formed by coupling a monoclonal antibody of p2PSA and latex microspheres with small particle sizes; the particle size range of the small-particle-size latex microspheres is 71-121 nm; the monoclonal antibody of the p2PSA comprises three strains of different monoclonal antibodies of the p2PSA; when the kit is used for determining the p2PSA, the sensitivity can be ensured, the linearity is widened, and the specificity is enhanced.
Owner:BEIJING QINGKE BIOTECHNOLOGY CO LTD

A dual-channel real-time fluorescence quantitative PCR detection method for quantitative detection of HBV DNA and RNA in blood

The present invention discloses a blood hepatitis B virus (HBV) DNA and RNA dual-channel real-time fluorescence quantitative PCR detection system, and a method for simultaneously detecting HBV DNA and RNA using the detection system. The detection system includes oligonucleotide primers, reverse anchor primers and probes for amplifying DNA and RNA. The detection system and method of the present invention can be used to prepare HBV diagnostic reagents or kits. The present invention can simultaneously detect HBV DNA and RNA in one detection, and the method is simple and fast.
Owner:PEKING UNIV

A targeted drug delivery system based on DNA tetrahedral nanoclusters and its construction method and application

The present invention provides a targeted drug delivery system based on DNA tetrahedron nanoclusters, a construction method and an application thereof. The targeted drug delivery system comprises a DNA tetrahedron assembled from 7 DNA probes, T4 DNA ligase, sgc8 nucleic acid aptamer and anthracycline anticancer drugs. The targeted drug delivery system has good serum stability, targeted selectivity, and ultra-high drug loading, and can selectively deliver anticancer drugs to target cells and kill cancer cells, showing great potential in anticancer treatment. In addition, the nucleic acid aptamers on the surface of the DNA tetrahedron nanoclusters will be non-specifically degraded during transportation, while the nucleic acid aptamers inside can move to the surface to compensate for the degradation of the surface nucleic acid aptamers, further maintaining the specificity of the nanoclusters, and this assembly method can ensure that the drug delivery system has an excellent targeting effect during the delivery process.
Owner:FUZHOU UNIV

Specific marker gene lhh2a.2.2 of spermatogonium of pseudosciaena crocea as well as screening method and application of specific marker gene lhh2a.2.2

The invention provides a specific marker gene lhh2a. 2.2 of spermatogonium of larimichthys crocea as well as a screening method and application of the specific marker gene lhh2a. 2.2, and belongs to the field of molecular markers and the field of germline stem cell research. According to the invention, the nucleotide sequence of the lhh2a. 2.2 gene is as shown in SEQ ID NO: 1; through screening and analysis of a single cell transcription sequencing technology, and through in-situ hybridization, Vasa gene and PCNA gene co-localization, it is determined that the lhh2a. 2.2 gene can specifically identify spermatogonium in a proliferation state; a core tool and a prerequisite condition can be provided for establishment of a high-efficiency germ cell transplantation technology, purification of spermatogonial stem cells for in-vitro culture and construction of a transgenic pseudosciaena crocea strain.
Owner:MARINE FISHERIES RES INST OF ZHEJIANG

Nucleic acid amplification and chromatography detection kit based on totally-enclosed card box ureaplasma urealyticum and application of nucleic acid amplification and chromatography detection kit

The invention relates to a nucleic acid amplification and chromatographic detection kit based on ureaplasma urealyticum in a totally-enclosed card box and application of the kit, the kit is a kit based on an RPA isothermal amplification chromatography technology, a freeze-drying ball reagent, a liquid reagent and a nucleic acid detection chromatographic test strip are arranged in the kit, the amplification mode is RPA isothermal amplification, and the detection sensitivity is high. The detection mode is a chromatographic test strip, the 5'end of a probe of the ureaplasma urealyticum RPA is marked with digoxin, and the 5 'end of a downstream primer is marked with biotin. The 5'end of the RPA probe of the internal standard substance bacillus is marked with FAM, and the 5 'end of the downstream primer is marked with biotin. Two indexes of UU and reference genes can be simultaneously amplified in the same tube through an RPA isothermal amplification method, an amplification product is double-stranded DNA with molecular markers at two ends, compared with fluorescent PCR, the kit integrates nucleic acid extraction, amplification and detection, the nucleic acid extraction, amplification and detection are all carried out in a card box in a sealed mode, a sample adding step is not needed, operation is simple, pollution can be effectively prevented, and the kit is suitable for large-scale popularization and application. And automation of the whole process is realized.
Owner:SUZHOU HUAZHEN MEDICAL LAB CO LTD

Highly fitting helmet-type primate magnetic resonance experiment radio frequency coil device

The present application discloses a high-fitting helmet-type primate magnetic resonance experiment radio frequency coil device, comprising: an animal fixing seat for fixing the animal to be tested, a helmet-type coil support shell connected to the animal fixing seat through a universal connecting rod and capable of being worn on the head of the animal to be tested, a radio frequency receiving coil arranged inside the coil support shell, and a signal wire connected to the radio frequency receiving coil circuit and extending outside the coil support shell. Regardless of the angle at which the head of the animal to be tested is fixed, the radio frequency receiving coil in the device can be arranged close to the scalp of the animal to be tested, thereby improving the signal-to-noise ratio of signal induction reception and the quality of magnetic resonance imaging. Regardless of the angle at which the head of the animal to be tested is fixed, the radio frequency receiving coil in the device can be arranged close to the scalp of the animal to be tested, thereby improving the signal-to-noise ratio of signal induction reception and the quality of magnetic resonance imaging.
Owner:ZHEJIANG UNIV

An early screening marker related to immune response in ischemic stroke based on Olink proteomics and its selection method and application

ActiveCN117969851Bguaranteed specificityimprove accuracyOmicsDisease diagnosisSTC1Biology
The present invention provides an ischemic stroke immune response-related early screening marker based on Olink proteomics, and a selection method and application thereof, and relates to the field of biomedical technology. The ischemic stroke immune response-related early screening markers are six proteins: MASP1, STC1, HCLS1, CLEC4D, PTH1R and PIK3AP1, and the six proteins can be used to establish an ischemic stroke detection model, assist in clinical diagnosis of ischemic stroke, and provide targets for mechanism research, and the six markers can be used to prepare an ischemic stroke early screening kit. The present invention overcomes the shortcomings of the prior art, determines the best protein marker combination for early screening of ischemic stroke through Olink proteomics technology, and effectively solves the problems of high cost, long time consumption, marker sensitivity, and insufficient specificity in existing ischemic stroke screening.
Owner:NINGBO INST OF LIFE & HEALTH IND UNIV OF CHINESE ACAD OF SCI

MuSK antibody detection method and corresponding product

The invention relates to a MuSK antibody detection method and a corresponding product. The polynucleotide adopted by the invention is the polynucleotide for coding the recombinant human Flag-MuSK-ECD protein, and the recombinant human Flag-MuSK-ECD protein has the advantages that the recombinant human Flag- The sequence of the recombinant human Flag-MuSK-ECD protein is as shown in SEQ ID NO. 2; the sequence of the polynucleotide is as shown in SEQ ID NO. 1. According to the MuSK antibody detection method, eukaryotic cells are transfected through artificially constructed target gene expression plasmids, secreting type Flag-MuSK-ECD protein in supernatant is collected, the secreting type Flag-MuSK-ECD protein is used as a detection antigen, and the MuSK antibody is detected through the detection antigen. Factors which influence antigen activity detection due to reasons such as detection of antigen species difference, expression of immature MuSK full-length protein by prokaryotic cells, low protein purification purity caused by partial anti-MuSK transmembrane segment and / or intracellular segment antibodies and a poor-specificity protein tag purification system are avoided, so that the antigen activity is relatively good; therefore, the specificity and the sensitivity of pathogenic antibody detection are improved, and a more valuable biomarker detection method is provided for clinical diagnosis and treatment schemes.
Owner:FU JIAN YI KE DA XUE FU SHU DI ER YI YUAN

DNA tetrahedron assembly and its application in the preparation of fluorescent probes for circular RNA imaging

The present invention belongs to the field of nano-biosensing, and specifically relates to a DNA tetrahedron combination and its application in preparing a fluorescent probe for circular RNA imaging. The DNA tetrahedron combination consists of TDN1 and TDN2, wherein: the TDN1 is formed by base complementary pairing of the DNA single strands shown in SEQ ID NO.1‑7; the TDN2 is formed by base complementary pairing of the DNA single strands shown in SEQ ID NO.1‑4 and SEQ ID NO.8, the 3′ end of the SEQ ID NO.6 is modified with a fluorescent quenching group, and the 53rd base at the 5′ end of the SEQ ID NO.5 is modified with a fluorescent reporter group. The DNA tetrahedron combination of the present invention uses entropy increase to drive the catalytic cycle reaction to accumulate fluorescent signals, and as a fluorescent probe, it has the advantages of high sensitivity, high specificity and high stability in circular RNA imaging.
Owner:SHENZHEN TECH UNIV

Analysis method for rapidly detecting aflatoxin B1 on site

The invention discloses a method for detecting aflatoxin B1 by using an on-site rapid test strip. According to the invention, a CRISPR / Cas12a system is combined with commercial early pregnancy test paper, the aflatoxin B1 extracted from food is specifically recognized by adopting a nucleic acid lock structure, a nucleic acid sequence in the lock structure is released to be combined with crRNA, the activity of CRISPR / Cas12a is started, and the concentration information of the aflatoxin B1 is converted into color information on the early pregnancy test paper by virtue of an hCG probe. And pictures are collected by photographing through the smart phone, and picture information is processed by software, so that the quantitative detection of the aflatoxin B1 in the food can be completed. According to the detection method, the detection cost and operation steps are greatly reduced, the sensitivity is high, the specificity is good, the lowest detection limit can reach 2.6 pg / mL, and the national detection standard is reached.
Owner:SICHUAN UNIV